Company intelligence / Profile preview

TaerimPharm

Seongnam-si, Gyeonggi-do, South Korea

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Pharmaking, formerly known as Taerim Pharmaceutical, is a South Korean pharmaceutical company specializing in the development and manufacture of hepatoprotective medicines. Founded in 1975, the company is a leader in the Korean hepatitis medicine market, notably for its flagship products Nissel and Pennel. Pharmaking focuses on R&D, investing a significant portion of its sales into developing new treatments for liver diseases and other adult diseases using both synthetic and natural substances. The company has expanded its reach globally, exporting products to Southeast Asia, Egypt, and the United States.

Therapeutic areas: GastroenterologyPulmonologyInfectious Diseases
Modalities: Small moleculeNatural substance
Industry: Biotech

Partnerships

UPC United Pharma CompanyUnico Alliance Company

Beyond the preview

Go deeper on TaerimPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TaerimPharm.

Explore the full profile